Share
1,875 Posts.
lightbulb Created with Sketch. 195
clock Created with Sketch. 18/12/19
09:54
Share
Originally posted by Ousia:
↑
This is very bad luck. A successful phase IIa that met safety and efficacy end points (the drug inhibited the right enzyme), but the program is cancelled due to the potential for a rare (but important) drug drug interaction in another small phase I. I guess the good news is that the market hadn't priced in a positive result anyway.
Expand
agree, someone will be fool to sell this now anything under 0.24c as the pxs sp was never pricing in this anyway bronchitol alone will be worth north of 0.50c from next year and I am putting 99% fda approval as otherwise they don’t talk about packaging of the products if the product itself isn’t getting approved!!
